{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:39:55Z","timestamp":1791218395027,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.nbd.2007.07.029","type":"journal-article","created":{"date-parts":[[2007,8,27]],"date-time":"2007-08-27T10:57:19Z","timestamp":1188212239000},"page":"41-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Increased metabolism in the R6\/2 mouse model of Huntington\u2019s disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Jorien M.M.","family":"van der Burg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Bacos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel I.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Lindqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Wierup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn I.","family":"Wamsteeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Deierborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Kuhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian P.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hindrik","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Erlanson-Albertsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Jennifer","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Brundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Peters\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt. 1","key":"10.1016\/j.nbd.2007.07.029_bib1","first-page":"37","article-title":"Quantitative histology of Wallerian degeneration: I. Nuclear population in rabbit sciatic nerve","volume":"80","author":"Abercrombie","year":"1946","journal-title":"J. Anat."},{"issue":"3","key":"10.1016\/j.nbd.2007.07.029_bib2","first-page":"223","article-title":"Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington disease: clinical consequences and therapeutic implications","volume":"18","author":"Aziz","year":"2007","journal-title":"Neurosci."},{"issue":"5717","key":"10.1016\/j.nbd.2007.07.029_bib3","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1126\/science.1109951","article-title":"The gut and energy balance: visceral allies in the obesity wars","volume":"307","author":"Badman","year":"2005","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.nbd.2007.07.029_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20624","article-title":"Mitochondria take center stage in aging and neurodegeneration","volume":"58","author":"Beal","year":"2005","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2007.07.029_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The R6\/2 transgenic mouse model of Huntington\u2019s disease develops diabetes due to deficient {beta}-cell mass and exocytosis","volume":"14","author":"Bjorkqvist","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.nbd.2007.07.029_bib6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic\u2013pituitary\u2013adrenal axis in the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"15","author":"Bjorkqvist","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.nbd.2007.07.029_bib7","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1037\/0735-7044.117.6.1233","article-title":"Exploratory activity and fear conditioning abnormalities develop early in R6\/2 Huntington\u2019s disease transgenic mice","volume":"117","author":"Bolivar","year":"2003","journal-title":"Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2007.07.029_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmet.2005.06.002","article-title":"Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3","volume":"2","author":"Brand","year":"2005","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.nbd.2007.07.029_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.peptides.2005.02.029","article-title":"The melanocortin system and energy balance","volume":"27","author":"Butler","year":"2006","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.nbd.2007.07.029_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.nbd.2007.07.029_bib11","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2007.07.029_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z","article-title":"Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington\u2019s disease gene","volume":"15","author":"Carter","year":"2000","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.nbd.2007.07.029_bib13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington\u2019s disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev., Neurosci."},{"issue":"13","key":"10.1016\/j.nbd.2007.07.029_bib14","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1073\/pnas.0306931101","article-title":"Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3\u201336)","volume":"101","author":"Challis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.nbd.2007.07.029_bib15","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/11.17.1939","article-title":"Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington\u2019s disease","volume":"11","author":"Chan","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.nbd.2007.07.029_bib63","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome. Res."},{"issue":"3","key":"10.1016\/j.nbd.2007.07.029_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.nbd.2007.07.029_bib17","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington\u2019s disease","volume":"59","author":"Djousse","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nbd.2007.07.029_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/hmg\/10.2.145","article-title":"Abnormalities in the functioning of adipocytes from R6\/2 mice that are transgenic for the Huntington\u2019s disease mutation","volume":"10","author":"Fain","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.nbd.2007.07.029_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","article-title":"Diabetes mellitus in Huntington disease","volume":"27","author":"Farrer","year":"1985","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2007.07.029_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.1320210213","article-title":"Anthropometric discrimination among affected, at-risk, and not-at-risk individuals in families with Huntington disease","volume":"21","author":"Farrer","year":"1985","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.nbd.2007.07.029_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng0397-269","article-title":"Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia","volume":"15","author":"Fleury","year":"1997","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2007.07.029_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(03)01081-X","article-title":"Obesity wars: molecular progress confronts an expanding epidemic","volume":"116","author":"Flier","year":"2004","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.nbd.2007.07.029_bib23","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1210\/en.2004-0938","article-title":"Reduced ghrelin, islet amyloid polypeptide, and peptide YY expression in the stomach of gastrin-cholecystokinin knockout mice","volume":"146","author":"Friis-Hansen","year":"2005","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.nbd.2007.07.029_bib24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group","volume":"72","author":"Group","year":"1993","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.nbd.2007.07.029_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nbd.2007.07.029_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.01.024","article-title":"Early behavioral deficits in R6\/2 mice suitable for use in preclinical drug testing","volume":"20","author":"Hickey","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.nbd.2007.07.029_bib27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington\u2019s disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.nbd.2007.07.029_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1677\/jme.1.01632","article-title":"Peripherally administered [Nle4,d-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL\/6 and ob\/ob mice","volume":"33","author":"Hoggard","year":"2004","journal-title":"J. Mol. Endocrinol."},{"issue":"9","key":"10.1016\/j.nbd.2007.07.029_bib29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tem.2004.09.010","article-title":"CART in feeding and obesity","volume":"15","author":"Hunter","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.nbd.2007.07.029_bib30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington\u2019s disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.nbd.2007.07.029_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.62.3.523-a","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"62","author":"Kassubek","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nbd.2007.07.029_bib32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpendmet0080","article-title":"Drug insight: the functions of ghrelin and its potential as a multitherapeutic hormone","volume":"2","author":"Kojima","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.nbd.2007.07.029_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","article-title":"Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine\u2013EGFP fluorescent aggregates","volume":"93","author":"Kotliarova","year":"2005","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.nbd.2007.07.029_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005072-199007000-00002","article-title":"Atrophy of the hypothalamic lateral tuberal nucleus in Huntington\u2019s disease","volume":"49","author":"Kremer","year":"1990","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2007.07.029_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3940(91)90443-W","article-title":"The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington\u2019s disease","volume":"132","author":"Kremer","year":"1991","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.nbd.2007.07.029_bib36","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.peptides.2005.11.027","article-title":"The role of CART in body weight homeostasis","volume":"27","author":"Larsen","year":"2006","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.nbd.2007.07.029_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10284150400011390","article-title":"Decreased UCP2 mRNA expression in rat stomach following vagotomy: novel role for UCP2 as free radical scavenger in the stomach?","volume":"7","author":"Lindqvist","year":"2004","journal-title":"Nutr. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2007.07.029_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.regpep.2005.05.002","article-title":"Overeating of palatable food is associated with blunted leptin and ghrelin responses","volume":"130","author":"Lindqvist","year":"2005","journal-title":"Regul. Pept."},{"issue":"2","key":"10.1016\/j.nbd.2007.07.029_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.0300-9475.2005.01550.x","article-title":"Influence on spontaneous tissue inflammation by the major histocompatibility complex region in the nonobese diabetic mouse","volume":"61","author":"Lindqvist","year":"2005","journal-title":"Scand. J. Immunol."},{"issue":"23","key":"10.1016\/j.nbd.2007.07.029_bib40","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2007.07.029_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","article-title":"Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington\u2019s disease: behavioral testing and impact of diabetes mellitus","volume":"126","author":"Luesse","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2007.07.029_bib42","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI104637","article-title":"A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study","volume":"41","author":"Luft","year":"1962","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.nbd.2007.07.029_bib43","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"17","key":"10.1016\/j.nbd.2007.07.029_bib44","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington\u2019s disease mouse models reveal context-independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.nbd.2007.07.029_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.nbd.2007.07.029_bib46","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/nm903","article-title":"Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma","volume":"9","author":"Mattiasson","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.nbd.2007.07.029_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ajcn\/50.1.145","article-title":"Nutritional evaluation of Huntington disease patients","volume":"50","author":"Morales","year":"1989","journal-title":"Am. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.nbd.2007.07.029_bib48","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","article-title":"Factors associated with slow progression in Huntington\u2019s disease","volume":"48","author":"Myers","year":"1991","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2007.07.029_bib49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic\u2013endocrine aspects in Huntington\u2019s disease","volume":"24","author":"Petersen","year":"2006","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2007.07.029_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington\u2019s disease","volume":"14","author":"Petersen","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.nbd.2007.07.029_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/1531-8249(200001)47:1<64::AID-ANA11>3.0.CO;2-S","article-title":"Higher sedentary energy expenditure in patients with Huntington\u2019s disease","volume":"47","author":"Pratley","year":"2000","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2007.07.029_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-0270(03)00227-9","article-title":"LABORAS: initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour","volume":"130","author":"Quinn","year":"2003","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.nbd.2007.07.029_bib53","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainres.2004.10.036","article-title":"A novel behavioural registration system LABORAS and the social interaction paradigm detect long-term functional deficits following middle cerebral artery occlusion in the rat","volume":"1031","author":"Quinn","year":"2005","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.nbd.2007.07.029_bib54","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/j.1468-1331.2006.01319.x","article-title":"Weight changes in Huntington\u2019s disease","volume":"13","author":"Robbins","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.nbd.2007.07.029_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5694\/j.1326-5377.1981.tb135681.x","article-title":"Body weight and dietary factors in Huntington\u2019s disease patients compared with matched controls","volume":"1","author":"Sanberg","year":"1981","journal-title":"Med. J. Aust."},{"issue":"6712","key":"10.1016\/j.nbd.2007.07.029_bib56","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/25341","article-title":"Mice lacking melanin-concentrating hormone are hypophagic and lean","volume":"396","author":"Shimada","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.nbd.2007.07.029_bib57","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2007.07.029_bib58","first-page":"305","article-title":"Neuropeptides in hypothalamic neuronal disorders","volume":"240","author":"Swaab","year":"2004","journal-title":"Int. Rev. Cyt."},{"issue":"2","key":"10.1016\/j.nbd.2007.07.029_bib59","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","article-title":"Assessment of the nutrition status of patients with Huntington\u2019s disease","volume":"20","author":"Trejo","year":"2004","journal-title":"Nutrition"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2007.07.029_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0376-6357(00)00135-2","article-title":"Validation of a new system for the automatic registration of behaviour in mice and rats","volume":"53","author":"Van de Weerd","year":"2001","journal-title":"Behav. Processes."},{"issue":"5","key":"10.1016\/j.nbd.2007.07.029_bib61","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2007.07.029_bib62","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107001830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107001830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:01:48Z","timestamp":1760850108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996107001830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0969996107001830"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2007.07.029","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased metabolism in the R6\/2 mouse model of Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2007.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}